KCM
Kennedy Capital Management Portfolio holdings
AUM
$4.19B
1-Year Return
21.14%
This Quarter Return
+9.84%
1 Year Return
+21.14%
3 Year Return
+81.48%
5 Year Return
+215.31%
10 Year Return
+405%
AUM
$4.19B
AUM Growth
+$8.49M
(+0.2%)
Cap. Flow
-$239M
Cap. Flow
% of AUM
-5.69%
Top 10 Holdings %
Top 10 Hldgs %
9.13%
Holding
690
New
48
Increased
226
Reduced
295
Closed
109
Top Buys
| 1 |
Genpact
G
|
+$15.3M |
| 2 |
SharkNinja
SN
|
+$11.8M |
| 3 |
Mercury Systems
MRCY
|
+$9.65M |
| 4 |
SPX Corp
SPXC
|
+$8.6M |
| 5 |
Old Second Bancorp
OSBC
|
+$8.54M |
Top Sells
| 1 |
Hexcel
HXL
|
+$22.7M |
| 2 |
Boot Barn
BOOT
|
+$18.9M |
| 3 |
Columbia Banking Systems
COLB
|
+$14.4M |
| 4 |
Chart Industries
GTLS
|
+$14M |
| 5 |
Informatica
INFA
|
+$13.8M |
Sector Composition
| 1 | Financials | 20.27% |
| 2 | Industrials | 19.02% |
| 3 | Healthcare | 16.19% |
| 4 | Technology | 14.06% |
| 5 | Consumer Discretionary | 8.67% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
526
CRA International
CRAI
$1.3B
| $733K | 0.02% |
3,910
+333
| +9% | +$62.4K |
|
|
ORKA
527
Oruka Therapeutics, Inc. Common Stock
ORKA
$601M
| $728K | 0.02% |
64,926
-823
| -1% | -$9.23K |
|
|
NVEE
528
DELISTED
NV5 Global
NVEE
| $717K | 0.02% |
31,033
-58,915
| -65% | -$1.36M |
|
529
Rithm Capital
RITM
$6.64B
| $702K | 0.02% |
+62,146
| New | +$702K |
|
530
Perella Weinberg Partners
PWP
$1.39B
| $677K | 0.02% |
34,839
+2,982
| +9% | +$57.9K |
|
531
Quest Resource Holding
QRHC
$35.4M
| $629K | 0.02% |
311,289
+107,107
| +52% | +$216K |
|
532
Roivant Sciences
ROIV
$9.21B
| $628K | 0.02% |
55,702
+2,109
| +4% | +$23.8K |
|
|
BPMC
533
DELISTED
Blueprint Medicines
BPMC
| $620K | 0.01% |
4,836
+213
| +5% | +$27.3K |
|
|
QIPT
534
Quipt Home Medical
QIPT
$113M
| $617K | 0.01% |
344,927
-3,281
| -0.9% | -$5.87K |
|
535
Sanofi
SNY
$116B
| $616K | 0.01% |
+12,755
| New | +$616K |
|
536
Orange County Bancorp
OBT
$349M
| $595K | 0.01% |
+23,025
| New | +$595K |
|
537
Key Tronic
KTCC
$35.2M
| $569K | 0.01% |
199,108
-24,341
| -11% | -$69.6K |
|
538
Biogen
BIIB
$21.1B
| $566K | 0.01% |
4,503
+52
| +1% | +$6.53K |
|
539
Alnylam Pharmaceuticals
ALNY
$63.2B
| $544K | 0.01% |
1,668
+127
| +8% | +$41.4K |
|
540
Twin Disc
TWIN
$192M
| $543K | 0.01% |
61,443
-49,423
| -45% | -$436K |
|
541
MIND Technology
MIND
$76.2M
| $512K | 0.01% |
60,708
-253,707
| -81% | -$2.14M |
|
542
Fortrea Holdings
FTRE
$914M
| $497K | 0.01% |
100,677
-111,459
| -53% | -$551K |
|
543
Ovid Therapeutics
OVID
$88.2M
| $496K | 0.01% |
1,502,329
-230,536
| -13% | -$76.1K |
|
544
Nuvalent
NUVL
$5.68B
| $420K | 0.01% |
5,504
+196
| +4% | +$15K |
|
545
Atlanticus Holdings
ATLC
$1.03B
| $406K | 0.01% |
7,423
-48,062
| -87% | -$2.63M |
|
546
Elutia
ELUT
$62.7M
| $387K | 0.01% |
195,399
-86,282
| -31% | -$171K |
|
547
Verastem
VSTM
$611M
| $374K | 0.01% |
90,203
+62,979
| +231% | +$261K |
|
548
Advantage Solutions
ADV
$623M
| $366K | 0.01% |
277,584
+23,880
| +9% | +$31.5K |
|
549
Portland General Electric
POR
$4.64B
| $307K | 0.01% |
7,555
-22,055
| -74% | -$896K |
|
550
Natera
NTRA
$24.2B
| $282K | 0.01% |
1,668
-1,756
| -51% | -$297K |
|